1-Bromopropane → HCID 54134500, compound
Reaction equation
C(N(C(C)C)[CH:4]([CH3:6])[CH3:5])C.Br[CH2:11][CH2:12][CH3:13].[NH2:14][CH2:15][C:16]1[O:20][N:19]=[C:18]([C:21]2[N:22]=[CH:23][N:24]3[C:30]4[CH:31]=[CH:32][S:33][C:29]=4[C:28](=[O:34])[N:27]4[CH2:35][CH2:36][CH2:37][C@H:26]4[C:25]=23)[N:17]=1>CN(C)C=O>[CH2:11]([N:14]([CH2:15][C:16]1[O:20][N:19]=[C:18]([C:21]2[N:22]=[CH:23][N:24]3[C:30]4[CH:31]=[CH:32][S:33][C:29]=4[C:28](=[O:34])[N:27]4[CH2:35][CH2:36][CH2:37][C@H:26]4[C:25]=23)[N:17]=1)[CH2:5][CH2:4][CH3:6])[CH2:12][CH3:13]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
1.74 ml (10 mmol) of N-ethyldiisopropylamine and 0.55 ml (6 mmol) of 1-bromopropane were added to a solution of 340 mg (1 mmol) of (S)-1-(5-aminomethyl-1,2,4-oxadiazol-3-yl)-10,11,12,12a-tetrahydro-8H-imidazo[5,1-c]pyrrolo[1,2-a]thieno[3,2-e][1,4]diazepin-8-one in 10 ml of dimethylformamide and the mixture was stirred at 70° for 12 hours. The reaction solution was subsequently evaporated and the residue was partitioned between methylene chloride and 2N sodium carbonate solution. The aqueous phase was washed three times with methylene chloride. The organic phases were dried with magnesium sulfate, filtered and evaporated. The residue obtained was chromatographed (silica gel, methylene chloride/methanol/aqueous ammonia 240:10:1). There were obtained 162 mg (38%) of (S)-1-(5-dipropylaminomethyl-1,2,4-oxadiazol-3-yl)-10,11,12,12a-tetrahydro-8H-imidazo[5,1-c]pyrrolo[1,2-a]thieno[3,2-e][1,4]diazepin-8-one, Rf=0.26 (silica gel, ethyl acetate/methanol 40:1).
Workup
- customThe reaction solution was subsequently evaporated
- customthe residue was partitioned between methylene chloride and 2N sodium carbonate solution
- washThe aqueous phase was washed three times with methylene chloride
- dry with materialThe organic phases were dried with magnesium sulfate
- filtrationfiltered
- customevaporated
- customThe residue obtained
- customwas chromatographed (silica gel, methylene chloride/methanol/aqueous ammonia 240:10:1)
Sources & evidence
- ORD record
- ord-576b48c4aba940f0a26d0a962a1883fe
- Source dataset
- uspto-grants-1997_09
- Patent number
- US05665718
Reaction notes
Loading…